Legal status · United States
Is Danuglipron legal in the United States?
No. Danuglipron is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Danuglipron in the United States at a glance
| Classification | Investigational, not approved |
|---|---|
| FDA approval status | Development discontinued; not approved |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Danuglipron profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Danuglipron is being studied in registered clinical trials but has not received FDA marketing approval in the United States.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Danuglipron is
Pfizer's oral small-molecule GLP-1 agonist whose development was discontinued after tolerability and safety signals.
Danuglipron was Pfizer's attempt at an oral small-molecule GLP-1 agonist to compete with injectable peptides. Despite showing weight loss in trials, the program faced high rates of gastrointestinal side effects and a liver-enzyme safety signal, and Pfizer discontinued its development.
Mechanism: Activates the GLP-1 receptor as an orally available small molecule rather than an injected peptide.
Regulatory history: Development discontinued; not approved
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Danuglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Danuglipron in other countries
Frequently asked questions
Is Danuglipron legal in the United States?
No. Danuglipron is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy Danuglipron in the United States?
No approved product exists to buy. In the United States Danuglipron is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Danuglipron FDA approved?
No. FDA status: Development discontinued; not approved. Current US classification: "Investigational, not approved". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Danuglipron live on its compound profile.
Danuglipron profileThis page is general information about the regulatory status of Danuglipron in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.